Skip to main content

Table 2 Use of prophylaxis during observation period

From: Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions

  All subjects (n = 220) 18-39 years (n = 160) ≥40 years (n = 60) p value
Prophylaxis, No (%) 155 (70) 120 (75) 35 (58) 0.0202
Stable regimen 103 (66) 77 (64) 26 (74) NS
Variable regimen: 52 (34) 43 (36) 9 (26) NS
  Started 11 (21) 8 (19) 3* (33) NS
  Changed 41 (79) 34 (79) 7 (78) NS
  Discontinued 11 (21) 7 (21) 2 (22) NS
Type of prophylaxis 1     
Continuous 144 (94) 112 (94) 32 (92) NS
Intermittent: 10 (6) 7 (6) 3 (8) NS
  Short-term 3 (2) 1 (1) 2 (6)  
  Intermediate 7 (5) 6 (5) 1 (3)  
  1. *All from the age 48–52 year age group.
  2. 1Data missing for 1 subject.